>

Allergan Stock Profile

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:4em;padding-top: 25px;;'>AL</div>

Performance

11 / 100

Odds of Distress

Equity ratings for Allergan Plc are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting November 27, 2019 and ending today February 25, 2020. Please note, there could be an existing legal relationship between Allergan Plc (AGN) and AdvisorShares Vice ETF (ACT). Click here to learn more.

Allergan Plc Profile

Next fiscal quarter end is expected on March 31, 2020. Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan Plc operates under Drug Manufacturers - General classification in USA and is traded on BATS Exchange. It employs 17400 people. more on Allergan Plc
Allergan Plc Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Allergan Plc SEC Filings
Allergan Plc SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameAllergan Plc
Related EntityACT (AdvisorShares Vice ETF)
ChairmanBrenton SaundersView All
Thematic Classifications
Active investing themes Allergan Plc currently participates. An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
showing 2 out of 3 themes  View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Allergan Plc
Piotroski F Score
Academic score to determine the current strength of Allergan Plc financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Financial Strength
Allergan Plc ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Debt to Equity Ratio
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Average Bond Rating: A+Very Firm
Profitability
Few selected profitability drivers of Allergan Plc representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
EBITDA Margin
Gross Margin
Profit Margin
Allergan Plc (AGN) is traded on BATS Exchange in USA. It is located in Clonshaugh Business and Technology Park and employs 17,400 people. Allergan Plc is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with total capitalization of 62.53 B. Allergan Plc runs under Healthcare sector within Drug Manufacturers?General industry. The entity has 328.1 M outstanding shares of which 13.7 M shares are presently shorted by investors with about 5.0 days to cover shorted positions. ALLERGAN INC has about 4.56 B in cash with 6.47 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.88.
Check Allergan Plc Probability Of Bankruptcy

Ownership Allocation (%)

Allergan Stock Price Odds Analysis

Odds Below 194.6HorizonTargetOdds Above 194.6
77.55%30 days 194.60 22.12%
Based on normal probability distribution, the odds of Allergan Plc to move above current price in 30 days from now is about 22.12 (This Allergan Plc probability density function shows the probability of Allergan Plc Stock to fall within a particular range of prices over 30 days) .

Allergan Stock Top Holders

Allergan Plc Income Statement Over Time

Allergan Stock Against Markets

Did you try this?

Run Idea Analyzer Now

   

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module

Allergan Plc Upcoming and Recent Events

Allergan Plc Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportMay 5, 2020
Next Earnings ReportAugust 4, 2020
Next Fiscal Quarter EndMarch 31, 2020
Next Fiscal Year EndFebruary 8, 2021
Last Quarter Report DateDecember 31, 2019
Last Earning Anouncement DateMarch 31, 2019

Allergan Plc Corporate Filings

Allergan Plc SEC Reporting

Unclassified Corporate Event
Financial Statements and Exhibits. Unclassified Corporate Event. Results of Operations and Financial Condition
Submission of Matters to a Vote of Security Holders
Other Events

Allergan Plc Distributions to stockholders

Allergan Plc Corporate Directors

Ronald Taylor Independent Director
Adriane Brown Independent Director
Robert Hugin Independent Director
Please continue to Trending Equities. Please also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Company logos by clearbit